||Recombinant human TIMP2 cDNA (27 – 220aa, derived from BC071586) fused with T7-His-TEV cleavage site Tag at N-terminal was expressed in E. coli.
||1.0 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, Sucrose and DTT.
||MASMTGGQQMGRGHHHHHHENLYFQGGECSCSPVHPQQAFCNADVVIRAKAVSEKEVDSGNDIYGNPIKRIQYEI KQIKMFKGPEKDIEFIYTAPSSAVCGVSLDVGGKKEYLIAGKAEGDGKMHITLCDFIVPWDTLSTTQKKSLNHRY QMGCECKITRCPMIPCYISSPDECLWMDWVTEKNINGHQAKFFACIKRSDGSCAWYRGAAPPKQEFLDIEDP
||>90% by SDS-PAGE
||1. May be used for in vitro TIMP2 mediated matrix metalloproteinases activities regulation study for cell differentiation or cancer cell metastasis with this protein either as soluble factor or as coating matrix protein.2. May be used for mapping TMP2 protein-protein interaction.3. Potential biomarker protein for diagnostic/prognosis, such as prostate or lung cancer.4. As immunogen for specific antibody production.
||Keep at -80 centigrade for long term storage. Product is stable at 4 centigrade for at least 7 days.